{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:59:38Z","timestamp":1786982378765,"version":"build-2736575974"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2022,2,2]],"date-time":"2022-02-02T00:00:00Z","timestamp":1643760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,2,2]],"date-time":"2022-02-02T00:00:00Z","timestamp":1643760000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31821003"],"award-info":[{"award-number":["31821003"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Key Research and Development Project","award":["2018AAA0100302"],"award-info":[{"award-number":["2018AAA0100302"]}]},{"name":"Shanghai Municipal Key Clinical Specialty","award":["shslczdzk02602"],"award-info":[{"award-number":["shslczdzk02602"]}]},{"name":"Shanghai Science and Technology Development Funds","award":["2020-SH-XY-2"],"award-info":[{"award-number":["2020-SH-XY-2"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Adv Ther"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1007\/s12325-021-01995-1","type":"journal-article","created":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T23:43:13Z","timestamp":1643758993000},"page":"1393-1402","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Disease Activity-Guided Stepwise Tapering but Not Discontinuation of Biologics Is a Feasible Therapeutic Strategy for Patients with Ankylosing Spondylitis: Real-World Evidence"],"prefix":"10.1007","volume":"39","author":[{"given":"Lingying","family":"Ye","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianye","family":"Bian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8588-118X","authenticated-orcid":false,"given":"Huji","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,2,2]]},"reference":[{"key":"1995_CR1","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.1136\/ard.2004.020875","volume":"63","author":"A Calin","year":"2004","unstructured":"Calin A, Dijkmans BA, Emery P, et al. Outcomes of a multicentre randomised clinical trial of etanercept to treat ankylosing spondylitis. Ann Rheum Dis. 2004;63:1594\u2013600. https:\/\/doi.org\/10.1136\/ard.2004.020875.","journal-title":"Ann Rheum Dis"},{"key":"1995_CR2","doi-asserted-by":"publisher","first-page":"2270","DOI":"10.1093\/rheumatology\/ker270","volume":"50","author":"R van den Berg","year":"2011","unstructured":"van den Berg R, Stanislawska-Biernat E, van der Heijde DM. Comparison of recommendations for the use of anti-tumour necrosis factor therapy in ankylosing spondylitis in 23 countries worldwide. Rheumatology (Oxford). 2011;50:2270\u20137. https:\/\/doi.org\/10.1093\/rheumatology\/ker270.","journal-title":"Rheumatology (Oxford)"},{"key":"1995_CR3","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1136\/annrheumdis-2016-210770","volume":"76","author":"D van der Heijde","year":"2017","unstructured":"van der Heijde D, Ramiro S, Landew\u00e9 R, et al. 2016 update of the ASAS-EULAR management recommendations for axial spondyloarthritis. Ann Rheum Dis. 2017;76:978\u201391. https:\/\/doi.org\/10.1136\/annrheumdis-2016-210770.","journal-title":"Ann Rheum Dis"},{"key":"1995_CR4","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1002\/art.39298","volume":"68","author":"MM Ward","year":"2016","unstructured":"Ward MM, Deodhar A, Akl EA, et al. American College of Rheumatology\/Spondylitis Association of America\/Spondyloarthritis Research and Treatment Network 2015 recommendations for the treatment of ankylosing spondylitis and nonradiographic axial spondyloarthritis. Arthritis Rheumatol. 2016;68:282\u201398. https:\/\/doi.org\/10.1002\/art.39298.","journal-title":"Arthritis Rheumatol"},{"key":"1995_CR5","doi-asserted-by":"crossref","unstructured":"Ward MM, Deodhar A, Gensler LS, et al. 2019 Update of the American College of Rheumatology\/Spondylitis Association of America\/Spondyloarthritis Research and treatment network recommendations for the treatment of ankylosing spondylitis and nonradiographic axial spondyloarthritis. Arthritis Care Res (Hoboken). 2019;71(10):1285\u201399.","DOI":"10.1002\/acr.24025"},{"issue":"1","key":"1995_CR6","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1136\/annrheumdis-2013-203419","volume":"73","author":"JS Smolen","year":"2014","unstructured":"Smolen JS, Braun J, Dougados M, et al. Treating spondyloarthritis, including ankylosing spondylitis and psoriatic arthritis, to target: recommendations of an international task force. Ann Rheum Dis. 2014;73(1):6\u201316. https:\/\/doi.org\/10.1136\/annrheumdis-2013-203419.","journal-title":"Ann Rheum Dis"},{"issue":"12","key":"1995_CR7","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.1136\/ard.2004.020875","volume":"63","author":"A Calin","year":"2004","unstructured":"Calin A, Dijkmans BA, Emery P, et al. Outcomes of a multicentre randomised clinical trial of etanercept to treat ankylosing spondylitis. Ann Rheum Dis. 2004;63(12):1594\u2013600. https:\/\/doi.org\/10.1136\/ard.2004.020875.","journal-title":"Ann Rheum Dis"},{"key":"1995_CR8","doi-asserted-by":"publisher","first-page":"2002","DOI":"10.1136\/ard.2009.124446","volume":"69","author":"B Glintborg","year":"2010","unstructured":"Glintborg B, Ostergaard M, Krogh NS, Dreyer L, Kristensen HL, Hetland ML. Predictors of treatment response and drug continuation in 842 patients with ankylosing spondylitis treated with anti-tumour necrosis factor: results from 8 years\u2019 surveillance in the Danish nationwide DANBIO registry. Ann Rheum Dis. 2010;69:2002\u20138. https:\/\/doi.org\/10.1136\/ard.2009.124446.","journal-title":"Ann Rheum Dis"},{"key":"1995_CR9","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1002\/acr.20258","volume":"62","author":"LE Kristensen","year":"2010","unstructured":"Kristensen LE, Karlsson JA, Englund M, Petersson IF, Saxne T, Geborek P. Presence of peripheral arthritis and male sex predicting continuation of anti-tumor necrosis factor therapy in ankylosing spondylitis: an observational prospective cohort study from the South Swedish Arthritis Treatment Group Register. Arthritis Care Res (Hoboken). 2010;62:1362\u20139. https:\/\/doi.org\/10.1002\/acr.20258.","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"10","key":"1995_CR10","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.3389\/fphar.2019.01476","volume":"17","author":"XJ Ji","year":"2019","unstructured":"Ji XJ, Wang YW, Hu ZY, Ma YP, Huang F. Effectiveness of subcutaneous tumor necrosis factor inhibitors in patients with ankylosing spondylitis: a real-world prospective observational cohort study in China. Front Pharmacol. 2019;17(10):1476. https:\/\/doi.org\/10.3389\/fphar.2019.01476.","journal-title":"Front Pharmacol"},{"issue":"7","key":"1995_CR11","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1007\/s10067-011-1722-5","volume":"30","author":"V Navarro-Compan","year":"2011","unstructured":"Navarro-Compan V, Moreira V, Ariza-Ariza R, Hernandez-Cruz B, VargasLebron C, Navarro-Sarabia F. Low doses of etanercept can be effective in ankylosing spondylitis patients who achieve remission of the disease. Clin Rheumatol. 2011;30(7):993\u20136. https:\/\/doi.org\/10.1007\/s10067-011-1722-5.","journal-title":"Clin Rheumatol"},{"key":"1995_CR12","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-018-1772-z","author":"J Gratac\u00f3s","year":"2019","unstructured":"Gratac\u00f3s J, Pontes C, Juanola X, et al. Non-inferiority of dose reduction versus standard dosing of TNF-inhibitors in axial spondyloarthritis. Arthritis Res Therapy. 2019. https:\/\/doi.org\/10.1186\/s13075-018-1772-z.","journal-title":"Arthritis Res Therapy"},{"issue":"7","key":"1995_CR13","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1136\/annrheumdis-2019-216839","volume":"79","author":"RBM Landew\u00e9","year":"2020","unstructured":"Landew\u00e9 RBM, van der Heijde D, Dougados M, et al. Maintenance of clinical remission in early axial spondyloarthritis following certolizumab pegol dose reduction. Ann Rheum Dis. 2020;79(7):920\u20138. https:\/\/doi.org\/10.1136\/annrheumdis-2019-216839.","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"1995_CR14","first-page":"884","volume":"36","author":"F Lian","year":"2018","unstructured":"Lian F, Zhou J, Wang Y, Chen D, Xu H, Liang L. Efficiency of dose reduction strategy of etanercept in patients with axial spondyloarthritis. Clin Exp Rheumatol. 2018;36(5):884\u201390.","journal-title":"Clin Exp Rheumatol"},{"issue":"3","key":"1995_CR15","doi-asserted-by":"publisher","first-page":"700","DOI":"10.5114\/aoms.2018.76141","volume":"15","author":"KP Li","year":"2019","unstructured":"Li KP, Jin JY, Yang JS, et al. Full dose, half dose, or discontinuation of etanercept biosimilar in early axial spondyloarthritis patients: a real-world study in China. Arch Med Sci. 2019;15(3):700\u20135. https:\/\/doi.org\/10.5114\/aoms.2018.76141.","journal-title":"Arch Med Sci"},{"key":"1995_CR16","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1177\/1759720X20929441","volume":"2","author":"T Zhang","year":"2020","unstructured":"Zhang T, Zhu J, He D, et al. Disease activity guided stepwise tapering or discontinuation of rhTNFR:Fc, an etanercept biosimilar, in patients with ankylosing spondylitis: a prospective, randomized, open-label, multicentric study. Ther Adv Musculoskelet Dis. 2020;2:12. https:\/\/doi.org\/10.1177\/1759720X20929441.","journal-title":"Ther Adv Musculoskelet Dis"},{"issue":"7","key":"1995_CR17","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1093\/rheumatology\/kew033","volume":"55","author":"N-C Victoria","year":"2016","unstructured":"Victoria N-C, Chamaida P-R, Eugenio DM, et al. Anti-TNF discontinuation and tapering strategies in patients with axial spondyloarthritis: a systematic literature review. Rheumatology. 2016;55(7):1188\u201394. https:\/\/doi.org\/10.1093\/rheumatology\/kew033.","journal-title":"Rheumatology"},{"key":"1995_CR18","doi-asserted-by":"publisher","unstructured":"Ruyssen-Witrand A, Rousseau V, Sommet A, et al. Factors associated with 5-year drugfree remission in early onset axial spondyloarthritis patients: data from desir cohort. Ann Rheum Dis. 2020;79:19. https:\/\/doi.org\/10.1136\/annrheumdis-2020-eular.3222.","DOI":"10.1136\/annrheumdis-2020-eular.3222"},{"issue":"7","key":"1995_CR19","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2018-028517","volume":"9","author":"L Uhrenholt","year":"2019","unstructured":"Uhrenholt L, Schlemmer A, Hauge E-M, et al. Dosage reduction and discontinuation of biological disease-modifying antirheumatic drugs in patients with rheumatoid arthritis, psoriatic arthritis and axial spondyloarthritis: protocol for a pragmatic, randomised controlled trial (the biological dose optimisation (BIODOPT) trial). BMJ Open. 2019;9(7): e028517. https:\/\/doi.org\/10.1136\/bmjopen-2018-028517.","journal-title":"BMJ Open"},{"issue":"1","key":"1995_CR20","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/s13063-019-4000-5","volume":"21","author":"CAJ Michielsens","year":"2020","unstructured":"Michielsens CAJ, Boers N, den Broeder N, et al. Dose reduction and withdrawal strategy for TNF-inhibitors in psoriatic arthritis and axial spondyloarthritis: design of a pragmatic open-label, randomized, non-inferiority trial. Trials. 2020;21(1):90. https:\/\/doi.org\/10.1186\/s13063-019-4000-5.","journal-title":"Trials"}],"container-title":["Advances in Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-021-01995-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12325-021-01995-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-021-01995-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,12]],"date-time":"2022-03-12T04:25:31Z","timestamp":1647059131000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12325-021-01995-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,2]]},"references-count":20,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["1995"],"URL":"https:\/\/doi.org\/10.1007\/s12325-021-01995-1","relation":{},"ISSN":["0741-238X","1865-8652"],"issn-type":[{"value":"0741-238X","type":"print"},{"value":"1865-8652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,2]]},"assertion":[{"value":"14 October 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 November 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 February 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}